Indonesia Probes Palm Oil Giants for Alleged UnderInvoicing Practices
BlackBerry Leverages Malaysia as Strategic Hub to Expand Cybersecurity Operations in Asia
Bitcoin Approaches 75K as Golden Cross Formation Captures Trader Attention Zcash Falls 9
Traders Bet on Nifty 16 Swing by Tuesday Using Long Straddle Amid West Asia Tensions
Pfizer Prevails in Singapore Trademark Dispute with Merck Over Vaccine Brand
Intercontinental Exchange to Launch GPU Compute Futures Suite Targeting Transparency in AI Infrastructure Costs
ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat
HTFC Q1 2026 Earnings Narrow EPS Miss Amid Stable Operations
FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand
ADMA Biologics Q1 2026 Earnings EPS Misses Estimates Amid Stock Downdraft
ELV Q1 2026 Earnings Strong Earnings Beat Overshadowed by Stock Decline
Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress
Maison Solutions Inc MSS Stock Hovers Near Key Support Amid Modest Uptick
Lamar Advertising LAMR Edges Higher as Investors Eye Key Resistance Level
Agriculture Natural Solutions Acquisition Corporation ANSC Holds Steady at 1136 Trading Within Established Range
Armada Acquisition Corp II Warrant XRPNW Surges 14 Amid Speculative Trading
High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility
India Captures Data Center Growth Despite Limited Direct AI Chip Sector Exposure
SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
Circle Internet Group CRCL Finds Demand at Support Closing Near Session Highs
First Mid Bancshares Holds Near Support Amid Modest Pullback
American Resources Corporation AREC Edges Higher as Stock Tests Support Levels
Dogness DOGZ Hovers Near Support After Slight Decline Resistance at 109 in Focus
ARB IOT Group ARBB Holds Near 503 as Narrow Trading Range Persists
Univest Financial UVSP Slides 113 as Regional Banking Sector Faces Headwinds
FACT II Acquisition Corp Warrant FACTW Slides 37 as Warrants Approach Key Support
TransCode Therapeutics RNAZ Drops 1066 Support at 53 Faces Critical Test After Sharp Decline